Elizabeth Holmes trial: jury to begin deliberations in Theranos founder?s case

After months of criminal proceedings that have gripped Silicon Valley, the fate of Theranos founder Elizabeth Holmes now rests in the hands of 12 jurors.

A group of eight men and four women will consider whether to convict or exonerate Holmes, 37, on nine counts of fraud and two counts of conspiracy to commit fraud. Deliberations are expected to begin on Monday.

Holmes faces a maximum of 20 years in prison and has pleaded not guilty.

Throughout the trial and in closing statements on Thursday, the prosecution sought to prove Holmes knowingly lied to investors and patients, arguing she purposely oversold the capabilities of the company's devices to attain wealth and fame.

Calling more than 30 witnesses including investors, patients, and former employees, lawyers for the prosecution painted a picture of a founder hell-bent on making her technology succeed despite mounting evidence that her claims were largely baseless.

Prosecutor Jeff Schenk presented to the jury a recap of arguments that Holmes knowingly lied about the capabilities of Theranos testing, saying the evidence shows "she made the decision to defraud her investors and then to defraud her patients"

"She chose fraud over business failure. She choose to be dishonest with investors and patients," he said. "That choice was not only callous, it was criminal."